1. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev. 2006;19(2):403-34.
2. Burgess M, Valdera F, Varon D, Kankuri E, Nuutila K. The immune and regenerative response to burn injury. Cells. 2022;11(19):3073.
3. Baj J, Korona-Głowniak I, Buszewicz G, Forma A, Sitarz M, Teresiński G. Viral infections in burn patients: a state-of-the-art review. Viruses. 2020;12(11):1315.
4. Shah NR, Palackic A, Brondeel KC, Walters ET, Wolf SE. The burn wound. Surgical Clinics of North America 2023;103(3):453-462.
5. Rowan MP, Cancio LC, Elster EA, Burmeister DM, Rose LF, Natesan S, Chan RK, Christy RJ, Chung KK. Burn wound healing and treatment: review and advancements. Crit Care. 2015;19:243.
6. Vinaik R, Barayan D, Shahrokhi S, Jeschke MG. Management and prevention of drug resistant infections in burn patients. Expert Rev Anti Infect Ther. 2019;17(8):607-619.
7. Żwierełło W, Piorun K, Skórka-Majewicz M, Maruszewska A, Antoniewski J, Gutowska I. Burns: classification, pathophysiology, and treatment: a review. Int J Mol Sci. 2023;24(4):3749.
8. Kiley JL, Greenhalgh D. Infections in the burn patient. Surgical Clinics of North America 2023;103(3):427-437.
9. Wurzer P, Guillory A, Parvizi D, Clayton RP, Branski LK, Kamolz LP, Finnerty CC, Herndon DN, Lee JO. Human herpes viruses in burn patients: a systematic review. Burns. 2017 ;43(1):25-33.
10. vanDuin D, Strassle PD, DiBiaseLM, et al. Timeline of health care-associated infections and pathogens after burn injuries. Am J Infect Control 2016;44:1511-1516.
11. Ladhani HA, Yowler CJ, Claridge JA. Burn wound colonization, infection and sepsis. Surg infect 2021;22:44-48.
12. Maslova E, Eisaiankhongi L, Sjöberg F, McCarthy RR. Burns and biofilms: priority pathogens and in vivo models. NPJ Biofilms Microbiomes. 2021 7(1):73.
13. Greenhalgh DG, Hill DM, Burmeister DM., et al Surviving sepsis after burn campaign. Burns 2023;49(7):1487-1524.
14. Sjöberg T, Mzezewa S, Jönsson K, Robertson V, Salemark L. Comparison of surface swab cultures and quantitative tissue biopsy cultures to predict sepsis in burn patients: a prospective study.
The journal of Burn Care & Rehabiltation 2003;24(6):365-370.
15. Tejiram S, Shupp JW. Sepsis in surgical patients: burn sepsis. Surgery 2024(175):1259 – 1261.
16. Bittner E, Sheridan R. Acute Respiratory Distress Syndrome, Mechanical Ventilation, and Inhalation Injury in Burn Patients. Surg Clin North Am. 2023 Jun;103(3):439-451.
17. Walker PF, Buehner MF, Wood LA, Boyer NL, Driscoll IR, Lundy JB, Cancio LC, Chung KK. Diagnosis and management of inhalation injury: an updated review. Crit Care. 2015 28;19:351.
18. Edelman DA, Khan N, Kempf K, et al. Pneumonia after inhalation injury. J Burn Care Res 2007;28:241-246.
19. Younan D, Griffin R, Zaky A, Pittet J-F, Camins B. Burn patients with infection-related ventilator associated complications have worse outcomes compared to those without ventilator associ-
ated events. Am J Surg 2018;215(4):678-681.
20. Gille J, Bauer N, Malcharek MJ, et al.Reducing the indication for ventilatory support in the severely burned patient: results of a new protocol approach at a regional burn center. Journal of
Burn Care & Research2016;37(3):e205-e212.
21. McWilliams TL, Twigg D, Hendricks J, Wood FM, Ryan J, Keil A. The implementation of an infection control bundle within a total care burns unit. Burns 2021;47:569-575.
22. Sen S, Johnston C, Greenhalgh D, Palmieri T. Ventilator-associated pneumonia prevention bundle significantly reduces the risk of ventilator -associated pneumonia in critically ill burn pa-
tients. J Burn Care Res 2016;37:166-171.
23. Ramos GE, Bolgiani AN, Patiño O, Prezzavento GE, Guastavino P, Durlach R, Fernandez Canigia LB, Benaim F. Catheter infection risk related to the distance between insertion site and
burned area. J Burn Care Rehabil. 2002;23(4):266-271.
24. Silva CLC, Rossi LA, daSilva Canini SRM, Goncalves N, Furuya RK. Site of catheter insertion in burn patients and infection: a systematic review. Burns 2014;40:365-373.
25. Li AT, Moussa A, Gus E, et al. Biomarkers for the early diagnosis of sepsis in burns: systematic review and meta-analysis. Annals of Surgery 2022;275(4):654-662.
26. Lavrentieva A, Papadopoulou S, Kioumis J, Kaimakamis E, Bitzani M. PCT as a diagnostic and prognostic tool in burn patients: whether time course has a role in monitoring sepsis treatment.
Burns 2012:38:356-363.
27. Chen Z, Turxun N, Ning F. Meta-analysis of the diagnostic value of procalcitonin in adult burn sepsis. Adv Clin Exp Med 2021:30:455-463.
28. Paratz JD, Lipman J, Boots RJ, Muller MJ, Paterson DL. A new marker of sepsis post burn injury? Crit Care Med 2014;42:2029-2036.
29. Jeon K, Lee N, Jeong S, Park MJ, Song W. Immature granulocte percentage for prediction of sepsis in severe burn patients: a machine learning-based approach. BMC Infect Dis 2021;21:1258.
30. Cakir Madenci O, Yakupoğlu S, Benzonana N, Yucel N, Akbaba D, Orcun Kaptanagasi A. Evaluation of soluble CD14 subtype (presepsin) in burn sepsis. Burns 2014;40:664-669.
31. Burmeister DM, Heard TC, Chao T, Alcover K, Wagner A, Chung KK, Akers KS. A prospective observational study comparing clinical sepsis criteria to protein biomarkers reveals a role for
vascular dysfunction in burn sepsis. Crit Care Explor. 2022;4(1):e0610.
32. Pedrosa AF, Rodrigues AG. Candidemia in burn patients: figures and facts. J Trauma. 2011;70(2):498-506.
33. Zhou J, Tan J, Gong Y, Li N, Luo G. Candidemia in major burn patients and its possible risk factors: A 6-year period retrospective study at a burn ICU. Burns 2019;45(5):1164–1171.
34. Ha JF, Italiano CM, Heath CH, Shih S, Rea S, Wood FM. Candidemia and invasive candidiasis: a review of the literature for the burn surgeon. Burns 2011;37:181-195.
35. Midilli K, Erkilic A, Kuskucu M, Analay H, Erkilic S, Benzonana N, Yildirim MS, Mulayim K, Acar H, Ergonul O. Nosocomial outbreak of disseminated orf infection in a burn unit, Gaziantep,
Turkey, October to December 2012. Eurosurveillance 2013;18:1–5.
36. Ramos G, Cornistein W, Cerino GT, Nacif G. Systemic antimicrobial prophylaxis in burn patients: systematic review. Journal of Hospital Infection 2017(97):105 – 114.
37. Tagami T, Matsui H, Fushimi K, Yasunaga H. Prophylactic antibiotics may improve outcome in patients with severe burns requiring mechanical ventilation: propensity score analysis of a
Japanese nationwide database. Clin Infect Dis 2016;62:60-66.
38. Avni T, Levcovich A, Ad-El DD, Leibovici L, Paul M. Prophylactic antibiotics for burns patients: systematic review and meta-analysis. BMJ. 2010;340:c241.
39. Merchant N, Smith K, Jeschke MG. An ounce of prevention saves tons of lives: infection in burns. Surg Infect (Larchmt). 2015;16(4):380-387.
40. Marcus JE, Townsend LC, Rizzo JA, James KA, Markelz AE, Blyth DM. Epidemiology and clinical significance of persistent bacteremia in severely burned patients. Burns; 2024 (50):375-380.
41. Fournier A, Eggimann P, Pantet O, et al. Impact of real-time therapeutic drug monitoring on the prescription of antibiotics in burn patients requiring admission to the intensive care unit.
Antimicrob Agents Chemother. 2018;62(3):e01818-17.
42. Corcione S, D’Avolio A, Corgiat Loia R, et al.Pharmakokinetics of meropenem in burn patients with infections caused by Gram-negative bacteria: are we getting close to the right treatment?
Journal of Global Antimicrobial Resistance 2020;20:22-27.
43. Blanchet B, Jullien V, Vinsonneau C, Tod M. Influence of burns on pharmakokinetics and pharmacodynamics of drugs used in the care of burn patients. Clin Pharmakokinet 2008;47(10):635-
654.
44. Çaydaşı Ö, Benzonana N, Can F, ve ark. Yanık yoğun bakım ünitesinde Gram-negatif bakteriyemisi olan hastalarda karbapenem direncinin belirlenmesi. Flora 2024;29(1):96-104.
45. Britton GW, WigginsAR, Halgas BJ, Cancio LC, Chung KK. Critical care of the burn patient. Surg Clin N Am 103 (2023) 415–426
46. Ziwa M, Jovic G, Hgwisha CLT, et al. Comman hydrotherapy practices and the prevalence of burn wound bacterial colonisation at the university teaching hospital in Lusaka, Zambia. Burns
2019;45:983-989.
47. Vickers ML, Malacova E, Milinovich GJ, et al. Modifiable risk factors for multidrug-resistant gram-negative infection in critically ill burn patients: a systematic review and meta-analysis. ANZ
Journal of Surgery 2019; 89: 1256-1260.
48. Lachiewicz AM, Hauck CG, Weber DJ, Cairns BA, van Duin D. Bacterial Infections after burn Injuries: impact of multidrug resistance. Clin Infect Dis. 2017;65(12):2130-2136.
49. Bache SE, Maclean M, Gettinby G, Anderson JG, MacGregor SJ, Taggart I. Airborne bacterial dispersal during and after dressing and bed changes on burns patients. Burns 2015;41:39-48